The nonprofit generic drugmaker will begin by manufacturing and distributing vancomycin and daptomycin before the end of the third quarter of this year.
To help manufacturer the products, Civica Rx has partnered with its first supplier, Xellia Pharmaceuticals, which will make the antibiotics for the more than 800 hospitals in the nonprofit’s network.
Under the agreement, the hospitals in the network will purchase antibiotics from Xellia for five years.
The antibiotics, which have been in and out of shortage, are key to hospital efforts to deal with drug-resistant infections.
Many brand-name drugmakers also have bowed out of the antibiotics industry in recent years.
The health systems formed Civica Rx last year to help address drug shortages and the rising costs of medications. They have committed to making 14 drugs this year.
More articles on pharmacy:
8 recent pharmaceutical lawsuits, settlements
McKesson renews distribution deal with CVS Health
Sacklers discussed selling Purdue Pharma in 2000, court documents reveal
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
